Colon Surgery Clinical Trial
Official title:
Impact of Intravascular Fluid Resuscitation on Whole Blood Viscosity During Colon Surgery
After obtaining approval from the Institutional Review Board of our institution, written
informed consent is obtained from patients undergoing colon surgery are enrolled in this
prospective study and randomly allocated into one of two groups: Group-C (n=15) and Group-HES
(n=15).
All recruited patients will be given patient identification number (PIN) for the present
study of 01-30 according to their order of interview and recruitment. Investigators will
prepare 15 yellow and 15 green cards, which will be inserted in 30 thick-paper envelopes.
Then, all envelopes will be sealed, mixed and randomly allocated to get numbers of 01 to 30
(Envelop number).
According to the color of the card, attending anesthesiologists will give crystalloid for
yellow card or HES for green cards, respectively, to maintain stroke volume variation < 15
during volume controlled ventilation (8 ml/kg tidal volume) of O2/air mixture.
Patient data and statistical analyses:
Patient's data whole blood viscosity, PaO2, FiO2, Hemoglobin, urine amount, s-glucose will be
determined from the patients' medical record after patient's discharge.
All statistical analyses will be performed after the 30th patient's discharge and data
acquisition
Status | Not yet recruiting |
Enrollment | 30 |
Est. completion date | December 2021 |
Est. primary completion date | October 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 19 Years and older |
Eligibility |
Inclusion Criteria: - Patients undergoing colon surgery - Patients provided a written informed consent. - Patients with preoperative serum hemoglobin concentration >13 g/dL (male) and >12 g/dL (female) - Patients with PaO2/FiO2 ratio >150 Exclusion Criteria: - Patients with history of anemia, dyspnea, active infection. - Patients with endocrine disease - Patients received or receiving intraoperative and preoperative blood salvaged, allogenic blood transfusion, anti-platelet drug, anti-fibrinolytic agents or recombinant human erythropoietin, or undergoing acute normovolemic hemodilution. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Konkuk University Medical Center |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | whole blood viscosity | whole blood viscosity measured by viscometer cm-1 | with 1 hour after the completion of procedure | |
Secondary | PaO2/FiO2 ratio | PaO2/FiO2 ratio measured by arterial blood gas analysis | 1 hour after the completion of procedure | |
Secondary | hematocrit | serum hematocrit, % | 1 hour after the completion of procedure | |
Secondary | glucose | serum glucose level, g/dl | 1 hour after the completion of procedure | |
Secondary | osmolarity | serum osmolarity, mOsm | 1 hour after the completion of procedure | |
Secondary | urine output | hourly urine output, ml/hr | 1 hour after the completion of procedure | |
Secondary | Maximum clot formation | Maximum clot formation in rotational thromboelastometry (ROTEM) analysis, mm | 1 hour after the completion of procedure |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00722709 -
Intraperitoneal Local Anaesthetic in Colonic Surgery
|
Phase 1 | |
Completed |
NCT03633123 -
D-PLEX 310: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection
|
Phase 2 | |
Completed |
NCT05681338 -
Effect of the Coughing Technique During Subcutaneous Heparin Injection
|
N/A | |
Completed |
NCT06020768 -
The Effect of Different Bed-Head Angles on the Haemodynamic Parameters of Intensive Care Patients Lying in the Supine Position
|
N/A | |
Completed |
NCT04233424 -
D-PLEX 311: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection
|
Phase 3 | |
Completed |
NCT05981937 -
ICG Anastomosis Control in Colon Surgery
|
||
Completed |
NCT01995591 -
Indocyanine Green (ICG) in the ex Vivo Detection of Sentinel Lymph Node (SLN)in Colon Cancer
|
N/A | |
Recruiting |
NCT04411199 -
D-PLEX 312 - Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection (SHIELD II)
|
Phase 3 |